BusinessThe New York Times
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.
Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.
By Alex Travelli
How does this story make you feel?
Public sentiment
0 reactions
Too early to tell
A mood appears once a few readers have reacted.
